Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
155.54
-2.89 (-1.82%)
Jul 28, 2026, 1:26 PM EDT - Market open
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $6.12 billion as of July 28, 2026. Its market cap has increased by 201.74% in one year.
Market Cap
6.12B
Enterprise Value
5.74B
1-Year Change
201.74%
Ranking
Category
Stock Price
$155.54
ChartMarket Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $6.12B, an increase of 4,132.45%. That is a compound annual growth rate of 141.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 6.03B | 0.54% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mirum Pharmaceuticals | 6.96B |
| Cogent Biosciences | 6.91B |
| Erasca | 6.55B |
| CG Oncology | 6.48B |
| Xenon Pharmaceuticals | 6.36B |
| PTC Therapeutics | 6.29B |
| Ligand Pharmaceuticals | 5.89B |
| Scholar Rock Holding | 5.86B |